Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B. [electronic resource]
- Expert review of gastroenterology & hepatology Apr 2020
- 243-251 p. digital
Publication Type: Journal Article; Review
1747-4132
10.1080/17474124.2020.1738219 doi
Antiviral Agents--therapeutic use Duration of Therapy Hepatitis B, Chronic--diagnosis Humans Nucleosides--analogs & derivatives Nucleotides Professional Practice Reverse Transcriptase Inhibitors--therapeutic use Secondary Prevention Treatment Outcome Withholding Treatment